Biocon's Stock Shows Mildly Bullish Trend Amid Profit Decline and High Debt Concerns
Biocon has recently experienced a change in its evaluation, indicating a shift in market sentiment. The company reported a return on capital employed of 4.1, but faced a significant profit decline of 77.7% over the past year. Its stock trades at a discount compared to peers, with increased institutional holdings.
Biocon, a midcap player in the Pharmaceuticals & Biotechnology sector, has recently undergone an adjustment in evaluation, reflecting a shift in its technical outlook. The stock's technical trend has transitioned from a sideways movement to a mildly bullish stance, indicating a change in market sentiment.In terms of key financial metrics, Biocon has reported a return on capital employed (ROCE) of 4.1, which suggests an attractive valuation relative to its enterprise value to capital employed ratio of 1.7. However, the company has faced challenges, with a significant decline in profits of 77.7% over the past year, contributing to a total return of -6.41% during the same period.
The stock is currently trading at a discount compared to its peers' average historical valuations, and institutional holdings stand at 28.86%, having increased by 7.47% from the previous quarter. Despite these factors, the company has a high debt to EBITDA ratio of 3.23 times, indicating a low ability to service its debt obligations.
Overall, Biocon's recent evaluation adjustment reflects a complex interplay of technical trends and financial metrics that merit close observation.
Discover the Latest Mojo Score and Financial Trend Performance - SignUp in less than 2 Minutes and get FREE Premium Access.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
